Picture of Heron Therapeutics logo

HRTX — Heron Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Heron Therapeutics Announces Partnership With Crosslink Life Sciences To Expand Promotional Effort For Zynrelef®, First And Only Non-Opioid Dual Acting Local Anesthetic For Post-Operative Pain

Jan 7 (Reuters) - Heron Therapeutics Inc  HRTX.O :
    * HERON THERAPEUTICS ANNOUNCES PARTNERSHIP WITH CROSSLINK
LIFE
SCIENCES TO EXPAND PROMOTIONAL EFFORT FOR ZYNRELEF®, FIRST AND
ONLY NON-OPIOID DUAL ACTING LOCAL ANESTHETIC FOR POST-OPERATIVE
PAIN

Source text for Eikon:  ID:nPn3sYDG1a 
Further company coverage:  HRTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Heron Therapeutics

See all news